Further, PTX@TNPs with a higher loading content of PTX (180 wt%) resulted in an over 1.5-fold higher synergistic anticancer effect in p-gp-overexpressing colorectal cancer cells compared with the free drug. This evidence concerns the gene PGP and colorectal cancer.